Summary
This 8-K filing from General Electric Company (GE) on October 10, 2003, details two significant strategic transactions that will reshape the company's media and life sciences operations. First, GE announced a definitive agreement to merge its NBC operations with Vivendi Universal Entertainment (VUE) to form a new entity, NBC Universal, which GE will own 80%. This move aims to create a leading media company, funded partly by GE issuing its common stock to cover the cash portion of the deal, which is expected to close in the first half of 2004. Second, GE agreed to acquire Amersham plc, a UK-based leader in medical diagnostics and life sciences. This share exchange transaction values Amersham at approximately $9.5 billion. The acquisition significantly expands GE's presence in the healthcare sector. Both transactions are subject to regulatory approvals, with completion anticipated in the first half of 2004, marking substantial portfolio changes for GE.
Key Highlights
- 1GE to merge NBC with Vivendi Universal Entertainment (VUE) to form NBC Universal, with GE holding an 80% stake.
- 2The NBC Universal transaction involves $3.8 billion in cash consideration for VUE shareholders and the assumption of $1.7 billion in debt.
- 3GE plans to issue its common stock to fund the cash component of the NBC Universal merger.
- 4GE to acquire Amersham plc, a global leader in medical diagnostics and life sciences, for approximately $9.5 billion (£5.7 billion).
- 5The Amersham acquisition will be a share exchange, with a specific exchange ratio to be determined at closing, capped at a maximum number of GE shares.
- 6Both the NBC Universal merger and the Amersham acquisition are anticipated to close in the first half of 2004, pending regulatory approvals.
- 7Amersham reported sales of $2.4 billion and net income of $269 million for the fiscal year ended December 31, 2002.